ARTL vs EG · $15.6M cap vs P/E 17, rev $8.03B
Artelo Biosciences Inc (ARTL) versus Everest Group Ltd (EG) — a side-by-side from cached financials, not a winner call.
Artelo Biosciences Inc (ARTL) is a biotechnology company listed on US.
Everest Group Ltd (EG) is a insurance - reinsurance company listed on US.
ARTL does not have a complete income-statement cache yet.
Latest reported EG revenue for 2026-06-30 was $8.03B. Net income was $1.21B. Revenue was up 97.4% from 2026-03-31 to 2026-06-30. EG currently screens at market cap $14.52B and trailing P/E 17.2.
ARTL currently screens at market cap $15.6M. EG currently screens at market cap $14.52B and trailing P/E 17.2.
Not investment advice. Open the ARTL and EG stock pages for the full models.
Not investment advice.